Skip to main content
Signal8

Chivukula Pad

SEC insider (Form 3/4/5 filer). CIK 0001727317. Chief Scientific Officer & COO at Arcturus Therapeutics Holdings Inc. (ARCT). 3 reported Form 4/5 transactions since Sep 2024; latest on Dec 17, 2025. Located in SAN DIEGO, CA.

Companies Chivukula Pad has filed insider reports for

  • Arcturus Therapeutics Holdings Inc. (ARCT): Officer, Chief Scientific Officer & COO
Chivukula Pad profile photo

Chivukula Pad

CIK: 0001727317

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Arcturus Therapeutics Holdings Inc. logo
ARCT

Arcturus Therapeutics Holdings Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Arcturus Therapeutics Holdings Inc. logo
    ARCT

    Arcturus Therapeutics Holdings Inc.

    Dec 17, 2025
    Award

    Employee Stock Option (right to buy)

    Direct
    54K shares-
  • Arcturus Therapeutics Holdings Inc. logo
    ARCT

    Arcturus Therapeutics Holdings Inc.

    Dec 16, 2024
    Award

    Employee Stock Option (right to buy)

    Direct
    60K shares-
  • Arcturus Therapeutics Holdings Inc. logo
    ARCT

    Arcturus Therapeutics Holdings Inc.

    Oct 15, 2024
    Sale
    Direct
    12K shares at avg. $20.76$249K

1-3 of 3